Factors Influencing Response to Aflibercept in Diabetic Macular Oedema Patients in a Diverse North West London Population: A Real-World Study
Sing Yue Sim,1 Arevik Ghulakhszian,2 Amal Minocha,1 Dhannie Ramcharan,2 Soroush Nokhostin,3 Richard Cheong-Leen,1 Sheena George,1 Esther Posner,3 Christiana Dinah2 1Department of Ophthalmology, The Hillingdon Hospitals NHS Foundation Trust, Uxbridge, UK; 2Department of Ophthalmology, London North We...
Enregistré dans:
Auteurs principaux: | Sim SY, Ghulakhszian A, Minocha A, Ramcharan D, Nokhostin S, Cheong-Leen R, George S, Posner E, Dinah C |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/e053bf9ab6514aaca7783976f516b13a |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Two Year Visual Acuity and Structural Outcomes in Patients with Diabetic Macular Oedema Treated with Intravitreal Aflibercept – A Retrospective Cohort Study
par: Kern C, et autres
Publié: (2020) -
Worsening anatomic outcomes following aflibercept for neovascular age-related macular degeneration in eyes previously well controlled with ranibizumab
par: Nudleman E, et autres
Publié: (2016) -
Real Life Experience of Dexamethasone Implant in Refractory Diabetic Macular Oedema
par: Karttunen T, et autres
Publié: (2019) -
Burden Of Treatment Among Patients Undergoing Intravitreal Injections For Diabetic Macular Oedema In Australia
par: Spooner KL, et autres
Publié: (2019) -
Efficacy of Aflibercept versus Ranibizumab in the treatment of diabetic macular edema
par: Xiu-Xian Wang, et autres
Publié: (2021)